(713) 357-9514

Reagents

Items 586 to 600 of 4584 total

per page
Page:
  1. 38
  2. 39
  3. 40
  4. 41
  5. 42

Set Descending Direction
  1. Biotium BNC882579-100, CD10 (Membrane Metalloendopeptidase)(MME/2579), CF488A conjugate, 0.1mg/mL
  2. Biotium BNC882579-500, CD10 (Membrane Metalloendopeptidase)(MME/2579), CF488A conjugate, 0.1mg/mL
  3. Biotium BNC882580-100, CD10 (Membrane Metalloendopeptidase)(MME/2580), CF488A conjugate, 0.1mg/mL
  4. Biotium BNC882580-500, CD10 (Membrane Metalloendopeptidase)(MME/2580), CF488A conjugate, 0.1mg/mL
  5. Biotium BNC882590-100, CD10 (Membrane Metalloendopeptidase)(MME/2590), CF488A conjugate, 0.1mg/mL
  6. Biotium BNC882590-500, CD10 (Membrane Metalloendopeptidase)(MME/2590), CF488A conjugate, 0.1mg/mL
  7. Biotium BNC882592-100, Aldo-keto Reductase Family 1 Member B1 (Adrenal Marker)(CPTC-AKR1B1-2), CF488A conjugate, 0.1mg/mL
  8. Biotium BNC882592-500, Aldo-keto Reductase Family 1 Member B1 (Adrenal Marker)(CPTC-AKR1B1-2), CF488A conjugate, 0.1mg/mL
  9. Biotium BNC882598-100, CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL
  10. Biotium BNC882598-500, CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL
  11. Biotium BNC882602-100, Calretinin / Calbindin 2 (Mesothelioma Marker)(CALB2/2602), CF488A conjugate, 0.1mg/mL
  12. Biotium BNC882602-500, Calretinin / Calbindin 2 (Mesothelioma Marker)(CALB2/2602), CF488A conjugate, 0.1mg/mL
  13. Biotium BNC882603-100, Calretinin / Calbindin 2 (Mesothelioma Marker)(CALB2/2603), CF488A conjugate, 0.1mg/mL
  14. Biotium BNC882603-500, Calretinin / Calbindin 2 (Mesothelioma Marker)(CALB2/2603), CF488A conjugate, 0.1mg/mL
  15. Biotium BNC882615-100, Cadherin 17 / LI Cadherin (Liver-Intestine Marker)(CDH17/2615), CF488A conjugate, 0.1mg/mL

Items 586 to 600 of 4584 total

per page
Page:
  1. 38
  2. 39
  3. 40
  4. 41
  5. 42

Set Descending Direction
© 2025 Sycamore Life Sciences, LLC. All Rights Reserved. All trademarks are property of their respective owners.